Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Lung Stem Cell Transplantation in IPF
NCT02745184Phase 2Completed
- Sponsor
- Shanghai East Hospital
- Start
- Mar 2017
- Primary completion
- Aug 2020
- Countries
- 1
01
Overview
Phase 2, open-label trial in idiopathic pulmonary fibrosis (IPF), sponsored by Shanghai East Hospital. Primary endpoint: Adverse Events at 24 weeks. Started Mar 2017; status: completed.
02
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT02745184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02745184.